Dawaa Reference

chronic

Malignant Neoplasm of the Ear (Ear Cancer)

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class HD25.01 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care · Suspected cancer: recognition and referral - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK555330/

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

1

NO DRUG THERAPY IN PRIMARY CARE (RECOGNITION & REFERRAL)

1st line
Adult dose and duration

Ear cancer is uncommon and treated with surgery, radiotherapy, or oncology-directed chemotherapy; the GP's role is urgent recognition and referral, not prescribing. - Refer

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

Ear cancer is uncommon and treated with surgery, radiotherapy, or oncology-directed chemotherapy; the GP's role is urgent recognition and referral, not prescribing.

Cautions
  • Rare in Egyptian primary care.
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - A non-healing ear ulcer or bleeding, a rapidly growing mass, or facial nerve palsy or persistent bloody ear discharge.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.